Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02690168 · ClinicalTrials.gov registry record
Testing Glial Pathways to HAAF in Human Subjects Using Carbon 13 Magnetic Resonance Spectroscopy
A clinical trial, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- 6
- Enrollment target
NCT02690168: Completed study, sponsored by Pennington Biomedical Research Center.
NCT02690168 is a clinical trial that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 6 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02690168 has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- 6 participants
- Enrollment target
Study Summary
Hypoglycemia-associated autonomic failure (HAAF), a condition commonly developed in diabetic patients, which causes them to have severely low blood sugar levels. This condition makes clinical management of blood sugar in diabetic patients very challenging. This research seeks to better understand how diabetic patients develop HAAF, and what can be done to prevent it.
Interventions
- BEHAVIORAL Fasting
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2016-02 |
| Est. Completion | 2017-07 |
What the finished NCT02690168 record still lists
NCT02690168 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 6 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Fasting is the first listed.
NCT02690168 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02690168 about?
NCT02690168 is a clinical study titled "Testing Glial Pathways to HAAF in Human Subjects Using Carbon 13 Magnetic Resonance Spectroscopy". Hypoglycemia-associated autonomic failure (HAAF), a condition commonly developed in diabetic patients, which causes them to have severely low blood sugar levels. This condition makes clinical management of blood sugar in diabetic patients very challenging. This research seeks to better understand ho...
What is the current status of trial NCT02690168?
This trial is currently completed. The enrollment target is 6 participants. The study started on 2016-02. Estimated completion is 2017-07.
What interventions are being tested in trial NCT02690168?
The interventions under investigation include: Fasting (BEHAVIORAL).
Who is sponsoring clinical trial NCT02690168?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia